Regulation of RXR-RAR Heterodimers by RXR- and RAR-Specific Ligands and Their Combinations
Open accessThe DOI matches its Crossref record; 81 of the 82 references it cites were found in a registry or an index.
Abstract
The three subtypes (α, β, and γ) of the retinoic acid receptor (RAR) are ligand-dependent transcription factors that mediate retinoic acid signaling by forming heterodimers with the retinoid X receptor (RXR). Heterodimers are functional units that bind ligands (retinoids), transcriptional co-regulators and DNA, to regulate gene networks controlling cell growth, differentiation, and death. Using biochemical, crystallographic, and cellular approaches, we have set out to explore the spectrum of possibilities to regulate RXR-RAR heterodimer-dependent transcription through various pharmacological classes of RAR- and RXR- specific ligands, alone or in combination. We reveal the molecular details by which these compounds direct specificity and functionality of RXR-RAR heterodimers. Among these ligands, we have reevaluated and improved the molecular and structural definition of compounds CD2665, Ro41-5253, LE135, or LG100754, highlighting novel functional features of these molecules. Our analysis reveals a model of RXR-RAR heterodimer action in which each subunit retains its intrinsic properties in terms of ligand and co-regulator binding. However, their interplay upon the combined action of RAR- and RXR-ligands allows for the fine tuning of heterodimer activity. It also stresses the importance of accurate ligand characterization to use synthetic selective retinoids appropriately and avoid data misinterpretations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






![Figure 7 3D crystal structure of RARβ and RXRα LBDs in complex with LG754 and a coactivator peptides. (A) cartoon representation of RARβ LBD. Helices are numbered from H1 to H12, the latest being the activation helix that adopts the agonist conformation. The coactivator peptide (SCR1 NR2) bound to the surface formed by H3, H4, and H12 of RARβ is shown in yellow. The ligand LG754 is shown by stick representation; (B) cartoon representation of RXRα LBD. The coactivator peptide (TIF2 NR2) bound to the protein is shown in yellow; (C) superposition of the two complexes of RARβ LBD bound to LG754 and coactivator peptide observed in the asymmetric unit; (D) superposition of our complex of RXRα LBD bound to LG754 and coactivator peptide (same as in B) with the crystal structure of RXRα LBD bound to LG754 in the context of the heterodimer RARα-RXRα [69] (PDB code 3a9e). In the latest structure, the activation helix H12 adopts an antagonist position protruding outside the LBD, whereas, in the present structure (PDB code 6sti), helix H12 (shown in red) folds back on the LBD in the agonist position.](https://figures.cochat.ai/paper-figures/cc086cf8f6f940cf88e5e8cf540c1dc8/regulation-of-rxr-rar-heterodimers-by-rxr-and-rar-specific-ligands-and-their-figure-7.jpg)
![Figure 8 Structural basis of LG754 activity in RARβ and RXRα. (A,B) close-up view of LG754 in the LBP of RARβ as observed in the two molecules of the asymmetric unit. Side chains of residues in close contact with the ligand are shown as yellow sticks. In both cases, hydrogen bonds between the carboxylate group of LG754, R269 in H5 and S280 in the β-turn are highlighted in dashed black line. The propoxy group of the ligand points either toward helices H6 and H7 (in a) or toward helix H12 (in b); (C) close-up view of the superposition of RXRα LBP bound to LG754 (in green, PDB code 6sti) with RXRα LBP bound to CD3254 (in pink, PDB code 3fug) [68]. The propoxy group of LG754 pointing toward H12 induces a reorientation of L436 from helix H11, as compared to its position in the RXRα-CD3254 complex, generating a steric clash with L455 of helix H12; (D) close-up view of the superposition of RXRα LBP bound to LG754 (in green, PDB code 6sti) with RXRα LBP bound to UVI3002 (in orange, PDB code 2p1v) [54]. The aliphatic extension of UVI3002 induces the same positioning of L436 and L455, as observed in the structure of RXRα bound to LG754.](https://figures.cochat.ai/paper-figures/4cdfe16d8bc34186b98dfe90ee5217e9/regulation-of-rxr-rar-heterodimers-by-rxr-and-rar-specific-ligands-and-their-figure-8.jpg)
![Figure 9 Conformation of the bound LG754 in RARβ and RXRα. (A) superposition of 9CRA as seen in the LBP of RXRα (PDB code 1fby) [70] and RARβ (PDB code 1xdk) [71]; (B) superposition of LG754 as seen in the LBP of RXRα (PDB code 6sti) and RARβ (PDB code 6ssq); (C) superposition of LG754 and 9CRA as seen in the LBP of RARβ (PDB code 6ssq) and of 9CRA as seen in the LBP of RARβ (PDB code 1xdk) [71]; (D) superposition of LG754 as seen in the LBP of RXRα (PDB code 6sti) and of 9CRA as seen in the LBP of RXRα (PDB code 1fby) [70].](https://figures.cochat.ai/paper-figures/5d4856f4573c46ae828711716349e3de/regulation-of-rxr-rar-heterodimers-by-rxr-and-rar-specific-ligands-and-their-figure-9.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“RAR and RXR constitute the two components of the dimer that serve to bind to retinoic acid response elements (RAREs) to activate the transcription of genes associated with the RARE.”
From Vitamin A Transporters in Visual Function: A Mini Review on Membrane Receptors for Dietary Vitamin A Uptake, Storage, and Transport to the Eye (2021) · cites this paper as [44]
The cited source says what the claim attributes to it.
In the citing paper
“One of the most important functions of all-trans retinoic acid is its contribution as a ligand in the RAR-RXR nuclear receptor.”
From Vitamin A Transporters in Visual Function: A Mini Review on Membrane Receptors for Dietary Vitamin A Uptake, Storage, and Transport to the Eye (2021) · cites this paper as [44]
In the citing paper
“In general, the fact that RXR acts as heterodimer-partner for several other NRs and neither RAR nor RXR are able to respond to agonists unless a ligand is bound to the heterodimeric partner, increases the complexity of RXR research.[187].”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [187]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
The CCP4 suite: programs for protein crystallography
Collaborative Computational Project, N. 4. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,270
The RXR heterodimers and orphan receptors
Mangelsdorf, D. J., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90200-7 · Cited by 3,158
A decade of molecular biology of retinoic acid receptors
Chambon, P. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.9.8801176 · Cited by 2,889
Hörlein, A. J., Näär, A. M., Heinzel, T., Torchia, J., Gloss, B., Kurokawa, R., Ryan, A., Kamei, Y., Söderström, M., Glass, C. K., et al. (1995) · Nature · doi:10.1038/377397a0 · Cited by 2,034
9-cis retinoic acid is a high affinity ligand for the retinoid X receptor
Heyman, R. A., Mangelsdorf, D. J., Dyck, J. A., Stein, R. B., Eichele, G., Evans, R. M., & Thaller, C. (1992) · Cell · doi:10.1016/0092-8674(92)90479-v · Cited by 1,780 · cited 1×
“In terms of ligand binding, RARs bind both all-trans- and 9-cis-RA stereoisomers, whereas RXRs bind only 9-cis-RA [38,39].”
BackgroundA transcriptional co-repressor that interacts with nuclear hormone receptors
Chen, J. D., & Evans, R. M. (1995) · Nature · doi:10.1038/377454a0 · Cited by 1,763
Combinatorial Control of Gene Expression by Nuclear Receptors and Coregulators
McKenna, N. J., & O'Malley, B. W. (2002) · Cell · doi:10.1016/s0092-8674(02)00641-4 · Cited by 1,463
The integration of macromolecular diffraction data
Leslie, A. G. W. (2006) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444905039107 · Cited by 1,341
Principles for modulation of the nuclear receptor superfamily
Gronemeyer, H., Gustafsson, J.-Å., & Laudet, V. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1551 · Cited by 1,226
Research works printed but not linked: 1
- Sporn, M.B., Roberts, A.B., and Goodman, D.S. (1984). The Retinoids, Academic Press Inc.
Cited by
Nuclear receptors are the major targets of endocrine disrupting chemicals
Toporova, L., & Balaguer, P. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.110665 · Cited by 179
Self-citationGarbern, J. C., & Lee, R. T. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02252-6 · Cited by 162
Bisphenol A and Phthalates in Diet: An Emerging Link with Pregnancy Complications
Filardi, T., Panimolle, F., Lenzi, A., & Morano, S. (2020) · Nutrients · doi:10.3390/nu12020525 · Cited by 121
Emerging concepts and opportunities for endocrine disruptor screening of the non-EATS modalities
Martyniuk, C. J., Martínez, R., Navarro‐Martín, L., Kamstra, J. H., Schwendt, A., Reynaud, S., & Chalifour, L. E. (2021) · Environmental Research · doi:10.1016/j.envres.2021.111904 · Cited by 72
The Role of Solute Carrier Transporters in Efficient Anticancer Drug Delivery and Therapy
Puris, E., Fricker, G., & Gynther, M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020364 · Cited by 58
Metadata
- Authors
- le Maire, A., Teyssier, C., Balaguer, P., Bourguet, W., & Germain, P.
- Affiliations
- Centre de Biochimie Structurale (CBS), CNRS, INSERM, Univ. Montpellier, ICM, 34090 Montpellier, France
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- Corresponding author
- Germain, Pierre
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2019-11-05
- Volume
- 8
- Issue
- 11
- Pages
- 1392
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC6912802
- OpenAlex
- W2987225062
- Cited by
- 88
- References
- 82
- Citations by year
- 2026: 4 · 2025: 11 · 2024: 14 · 2023: 17 · 2022: 16 · 2021: 16 · 2020: 9 · 2019: 1
- FWCI
- 3.47
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, cc-by-sa)
- HAL (submittedVersion)
- HAL (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Agence Nationale pour la Recherche (ANR-13-BSV6-000301))
- Association pour la Recherche sur le Cancer (ARCA08/4/1056)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- retinoid X receptor, retinoic acid receptor, ligand-dependent transcription, coregulators, ligand specificity, retinoic acid signaling
- MeSH terms
- Adamantane, Benzoates, Binding Sites, Cell Line, Chromans, Dibenzazepines, Humans, Ligands, Retinoids, Tetrahydronaphthalenes, Receptors, Retinoic Acid, Dimerization, Protein Subunits, Cell Line, Tumor, Retinoid X Receptors, MCF-7 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Regulation of RXR-RAR Heterodimers by RXR- and RAR-Specific Ligands and Their Combinations. https://app.cochat.ai/papers/10.3390/cells8111392
- The paper
- le Maire, A., Teyssier, C., Balaguer, P., Bourguet, W., & Germain, P. (2019). Regulation of RXR-RAR Heterodimers by RXR- and RAR-Specific Ligands and Their Combinations. Cells. https://doi.org/10.3390/cells8111392
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.